We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TV:NYSEGrupo Televisa S.A.B. Analysis

Data as of 2026-05-28 - not real-time

$2.82

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Grupo Televisa (TV) trades at a steep discount to peers, with valuation multiples far below industry averages and a forward price‑to‑earnings ratio that signals potential upside. Technical indicators show a neutral price trend, a bullish MACD signal, and a price hovering just above a key support level, while volume is declining and volatility remains elevated. The company’s dividend yield is attractive, and the payout ratio is minuscule, suggesting the dividend is well‑sustained despite modest free cash flow. Recent commentary highlights the prospect of debt reduction, possible M&A activity, and the upcoming 2026 Soccer World Cup as catalysts that could improve earnings and cash generation. However, the firm still reports negative profit margins and a high debt‑to‑equity ratio, indicating that earnings recovery is not guaranteed.
Investors should weigh the compelling valuation and dividend income against the lingering profitability concerns and elevated market volatility. The short‑term outlook is mixed, but the medium‑term narrative is driven by strategic opportunities and a re‑rating of the stock’s risk profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bullish MACD
  • High dividend yield providing downside cushion
  • Elevated volatility and decreasing volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount to industry peers
  • Potential debt reduction and M&A catalysts
  • Sustained dividend and low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent negative profit margins and high leverage
  • Strategic upside from 2026 Soccer World Cup exposure
  • Fundamental re‑rating dependent on earnings turnaround

Key Metrics & Analysis

Financial Health

Revenue Growth-3.10%
Profit Margin-14.48%
P/E Ratio7.6
ROE-7.60%
ROA1.57%
Debt/Equity84.88
P/B Ratio0.3
Op. Cash Flow$19.1B
Free Cash Flow$2.4B
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI44.9
Support$2.73
Resistance$2.99
MA 20$2.84
MA 50$2.92
MA 200$2.86
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

Target Price$3.86
Upside/Downside36.97%
GradeUndervalued
TypeValue
Dividend Yield3.22%

Risk Assessment

Beta0.73
Volatility38.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.